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LETTER TO THE EDITOR
Co-carcinogenic effect of sulphasalazine
Sir - The recent papeer by Davis et al. (British Journal of
Cancer (1992), 66, 777-780) presents evidence that drugs
used in the therapy of inflammatory bowel disease (IBD)
may be co-carcinogenic. The study reported was based on the
exposure of rats to a combination of the carcinogen
dimethylhydrazine (DMH) and doses of dugs that are in
excess of those used for clinical maintenance of IBD. The
explanation offered for some of the results, in particular
those of sulphasalazine, is not compatible with the model
employed.
The DMH model is an attractive one. Dimethylhydrazine
undergoes conjugation with subsequent secretion into the bile
and the liberation of the free N-hydroxy compound by the
colonic flora (Enker et al., 1976), thus mimicking the course
of potential dietary carcinogens. Neoplastic change occurs
through the formation and persistance of methylated purines
(Cooper et al., 1978). In human sporadic colon adenocar-
cinoma, however, the evidence points towards DNA hypo-
methylation as the significant factor in oncogene expression
(Feinberg & Vogelstein, 1983).
The authors suggest that sulphasalazine may be co-car-
cinogenic on account of the anti-folate nature of its sul-
phonamide moiety. The most likely mechanism for such an
influence would be through reduced levels of the one-carbon
donor S-Adenosylmethionine, or, through reduced levels of
5,10-Methylenetetrahydrofolate required for thymidine syn-
thase activity. As DNA hypomethylation may result from
either of these circumstances a DMH model does not provide
a sound support for the authors' conclusion.
The implication of the anti-folate action of sulphasalazine
is an extension of the theory that localised tissue folate
deficiency may underly carcinogenesis. Such a state has been
postulated to be a factor in the development of colonic
dysplasia (Lashner et al., 1989); cervical dysplasia (Butter-
worth et al., 1992) and bronchial squamous metaplasia
(Heimburger et al., 1988). In no instance has actual local
deficiency been demonstrated. Although it is conceivable that
such a state may exist in cells completely dependent on blood
stream nutrients this may not be the case in the colon.
Human colonocytes express folate receptors on their luminal
surfaces and in vitro are capable of transporting folates (Zim-
merman, 1990). It is possible that these cells may utilise
folates present in faeces so abrogating the potential effect of
drugs like sulphasalazine. In rats, as used in this study, the
situation is clearer, Rong et al. (1991) have shown that
colonic bacterial folate is incorporated into the hepatic folate
pool.
In conclusion, the study by Davis et al. highlights a need
for further investigation into any potential deleterious effects
of the medications used in IBD. However, to lay blame at
the door of an anti-folate effect remains unjustified.
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